Chicago, IL, United States of America

Norton Peet


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norton Peet: Innovator in Influenza Treatment

Introduction

Norton Peet is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the development of therapeutic options for influenza infections. His work addresses the urgent need for effective treatments that can be rapidly deployed in response to seasonal influenza outbreaks.

Latest Patents

Norton Peet holds a patent for "Inhibitors of influenza viral entry." This patent highlights the challenges associated with seasonal influenza vaccinations, which typically require at least six months to develop for circulating strains. Peet's invention focuses on fast-acting, orally active acylated amino-substituted heterocyclyl compounds that are effective in controlling the influenza virus. The patent describes a method of treating influenza infections by administering these compounds to affected subjects.

Career Highlights

Throughout his career, Norton Peet has worked with esteemed institutions such as the University of Illinois and Chicago Biosolutions, Inc. His experience in these organizations has allowed him to contribute to significant advancements in medical research and therapeutic development.

Collaborations

Norton Peet has collaborated with notable colleagues, including Lijun Rong and Irina Gaisina. These partnerships have fostered innovation and have been instrumental in advancing research in the field of influenza treatment.

Conclusion

Norton Peet's work in developing new therapeutic options for influenza infections showcases his commitment to addressing public health challenges. His innovative approach and patent contributions are vital in the ongoing fight against influenza viruses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…